StockWatch
·
Specialty Chemicals
Board Meeting24 Jul 2026, 07:30 pm

Neogen Chemicals Board Approves Q1 FY27 Un-audited Results, Annual Report

AI Summary

Neogen Chemicals Limited's Board of Directors convened on July 24, 2026, approving the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board also approved the integrated annual report for FY 2025-26, including various related reports and the notice for the 37th Annual General Meeting (AGM). The AGM is scheduled for August 21, 2026, with August 13, 2026, set as the record date for dividend eligibility. Additionally, the company received in-principle approval to raise funds up to ₹600 crores and appointed CNK & Associates as Internal Auditor for FY 2026-27. The Board also approved an increase in borrowing powers for its subsidiary, Neogen Morita New Materials Limited (NML), up to ₹500 Crore.

Key Highlights

  • Approved un-audited financial results for Q1 FY27 (standalone & consolidated).
  • Approved integrated annual report for FY 2025-26.
  • 37th AGM scheduled for August 21, 2026; record date August 13, 2026.
  • In-principle approval to raise funds up to ₹600 crores.
  • Appointed CNK & Associates as Internal Auditor for FY 2026-27.